Section 32
Section 32 is a venture capital firm founded by Bill Maris, the founder of Google Ventures (GV). The firm invests at the intersection of life sciences, healthcare, and frontier technology, with a focus on computational biology, genomics, and AI-driven healthcare solutions.
Website
https://section32.comLocation
Burlingame, California, USA
Founded
2017
AUM
$1B+
Investment Range
$5M - $50M
Portfolio Companies
1
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth
Investment Thesis
Section 32 invests in companies leveraging technology to transform healthcare and life sciences. The firm focuses on the convergence of computational biology, artificial intelligence, and healthcare delivery, seeking founders who are building transformative solutions for complex biological and medical challenges.
Team
Partners / Managing Directors
- Bill Maris - Founder & Managing Partner
- David Weisman - Partner
- Samir Kaul - Venture Partner
Other Key Team Members
- Alex Formoso - Principal
Focus Areas
- Computational Genomics
- Artificial Intelligence in Healthcare
- Genetic Engineering
- Diagnostics
- Digital Health
- Drug Discovery
- Longevity & Aging
Notable Portfolio Companies
- Verily - Precision health (Alphabet company)
- Freenome - Early cancer detection through AI
- Grail - Multi-cancer early detection (acquired by Illumina)
- Notable Labs - Predictive precision medicine
- Recursion - AI-driven drug discovery
Notable Exits
- Grail - Acquired (2021, acquired by Illumina for $8B)
- 23andMe - IPO (2021, NASDAQ: ME via SPAC)
Sources
- Section 32 website: https://section32.com
- Crunchbase: https://www.crunchbase.com/organization/section-32
- TechCrunch articles on Bill Maris and Section 32
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Verily Life Sciences | South San Francisco, California, USA | 2015 | healthcare-platformmedical-device+3 |